Security
PetVivo Holdings Inc. Common Stock · PETV
PETVOTCCommon stockCurrentCIK 1512922Updated Oct 26, 2026
Name history
Technologies Scan Corp · through May 2, 2014
PETV price & chart
Loading TradingView…
OTC:PETV on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
4 filing
4 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
4 filing
Financials
FY 2026 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 4,376,154Source | 3,112,340Source | 3,629,802Source | 5,258,269Source | 3,186,744Source | 2,669,481Source | 6,890,496Source | 2,888,930Source | 3,576,741Source | 9,339,195Source | 3,115,253Source | 2,438,952Source |
| Property, Plant and Equipment, NetUSD | 463,630Source | 770,267Source | 823,280Source | 482,885Source | 777,330Source | 447,089Source | 487,618Source | 805,570Source | 448,881Source | 766,874Source | 821,656Source | 630,852Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 28,891Source | 80,085Source | — | 126,239Source | — | — | 12,414Source | — | — | 87,403Source | 475,314Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 29,862Source | 493,121Source | 518,686Source | 137,999Source | 133,680Source | 83,792Source | 25,948Source | 72,026Source | 100,843Source | 60,573Source | 18,669Source | 86,689Source |
| Inventory, NetUSD | 605,390Source | 353,307Source | 467,467Source | 578,293Source | 372,115Source | 451,334Source | 529,342Source | 383,577Source | 538,366Source | 323,504Source | 390,076Source | 370,283Source |
| Assets, CurrentUSD | 1,383,278Source | 1,226,829Source | 1,492,884Source | 2,109,723Source | 1,246,384Source | 941,019Source | 4,400,859Source | 880,065Source | 1,859,921Source | 5,609,567Source | 1,041,660Source | 1,423,980Source |
| Prepaid Expense and Other Assets, CurrentUSD | 377,362Source | 351,510Source | 426,646Source | 475,517Source | 614,350Source | 283,260Source | 391,725Source | 412,048Source | 269,930Source | 447,801Source | 545,512Source | 491,694Source |
| Operating Lease, Right-of-Use AssetUSD | 70,560Source | 1,055,150Source | 1,253,815Source | 86,318Source | 1,101,557Source | 38,654Source | 102,035Source | 1,147,939Source | 54,711Source | 961,539Source | 1,194,348Source | 317,981Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 997,404Source | 3,807,121Source | 2,734,702Source | 1,075,297Source | 2,777,573Source | 1,313,312Source | 3,159,519Source | 2,059,427Source | 1,377,292Source | 5,119,947Source | 2,429,300Source | 1,713,927Source |
| Commitments and ContingenciesUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 34,451Source | 21,252Source | 14,921Source | 32,955Source | 20,067Source | 37,595Source | 24,402Source | 19,905Source | 35,850Source | 24,182Source | 17,059Source | 10,950Source |
| Additional Paid in CapitalUSD | 102,326,693Source | 88,059,840Source | 81,055,786Source | 100,815,956Source | 87,275,939Source | 104,316,968Source | 97,236,660Source | 85,655,985Source | 103,584,614Source | 95,385,511Source | 83,468,218Source | 72,420,604Source |
| Retained Earnings (Accumulated Deficit)USD | -98,987,394Source | -88,778,918Source | -80,148,607Source | -96,670,939Source | -87,021,880Source | -103,051,394Source | -93,538,130Source | -84,846,387Source | -102,075,765Source | -91,198,490Source | -82,799,324Source | -71,844,029Source |
| Stockholders' Equity Attributable to ParentUSD | 3,378,750Source | -694,781Source | 895,100Source | 4,182,972Source | 409,171Source | 1,356,169Source | 2,967,718Source | 829,503Source | 2,199,449Source | 4,219,248Source | 685,953Source | 725,025Source |
| Liabilities and EquityUSD | 4,376,154Source | 3,112,340Source | 3,629,802Source | 5,258,269Source | 3,186,744Source | 2,669,481Source | 6,890,496Source | 2,888,930Source | 3,576,741Source | 9,339,195Source | 3,115,253Source | 2,438,952Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 988,421Source | 2,936,314Source | 1,662,120Source | 1,052,694Source | 1,858,017Source | 1,313,312Source | 3,117,433Source | 1,091,181Source | 1,377,292Source | 4,316,800Source | 1,412,370Source | 1,453,680Source |
| Operating Lease, Liability, CurrentUSD | 61,577Source | 191,766Source | 196,263Source | 63,715Source | 191,373Source | 38,654Source | 63,380Source | 190,980Source | 54,711Source | 163,834Source | 190,589Source | 78,149Source |
| Accounts Payable, CurrentUSD | 385,641Source | 1,028,679Source | 1,094,152Source | 370,243Source | 762,103Source | 453,291Source | 744,392Source | 646,360Source | 547,421Source | 821,081Source | 821,230Source | 588,713Source |
| Operating Lease, Liability, NoncurrentUSD | 8,983Source | 863,384Source | 1,057,552Source | 22,603Source | 910,184Source | — | 38,655Source | 956,959Source | — | 797,705Source | 1,003,759Source | 239,832Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 541,203Source | 410,056Source | 241,959Source | 618,736Source | 395,625Source | 344,911Source | 846,378Source | 246,378Source | 453,713Source | 948,554Source | 243,030Source | 779,882Source |
| Short-term InvestmentsUSD | — | — | — | — | — | — | — | — | 150,000Source | — | — | — |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 134,671Source | 117,890Source | 511,457Source | 174,590Source | 126,850Source | 114,434Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 460,609Source | 133,197Source | 1,879,890Source | 1,107,520Source | 2,109,783Source | 1,462,768Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -17,051Source | -34,625Source | 45,144Source | 41,904Source | -68,020Source | 84,093Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -87,032Source | 205,838Source | 454,797Source | -66,572Source | 19,793Source | 271,970Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -965,779Source | -1,633,755Source | -6,107,286Source | -5,321,953Source | -7,419,588Source | -6,794,483Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -12,370Source | — | 11,800Source | -563,434Source | -309,104Source | -423,934Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 12,370Source | — | 7,734Source | 63,434Source | 309,104Source | 423,934Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 900,000Source | 4,709,910Source | 6,068,579Source | 6,025,673Source | 7,340,781Source | 1,586,904Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -78,149Source | 3,076,155Source | -26,907Source | 140,286Source | -387,911Source | -5,631,513Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 2,635Source | 21,801Source | 8,360Source | 1,573Source | 2,842Source |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | 100,000Source | 0Source | 100,000Source | 0Source | 100,000Source | 100,000Source | 400,000Source | 50,000Source | — | — |
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | 132,133Source | 74,024Source | — | — | — | 1,462,768Source |
| Amortization of Intangible AssetsUSD | — | — | 658Source | 1,379Source | 870Source | 1,382Source | 509Source | 1,230Source | 3,216Source | 6,374Source | 8,550Source | 9,803Source |
| DepreciationUSD | — | — | 14,059Source | 30,695Source | 17,661Source | 31,661Source | 14,162Source | 16,659Source | 63,131Source | 118,216Source | 118,300Source | 104,631Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | -149,125Source | -149,125Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | -534,366Source | — |
| General and Administrative ExpenseUSD | — | — | 1,252,406Source | 1,184,807Source | 1,236,730Source | 1,267,117Source | 967,442Source | 1,068,818Source | 4,333,577Source | 4,823,230Source | 6,693,186Source | 5,022,943Source |
| InterestExpenseNonoperatingUSD | — | — | — | 24,378Source | 942,442Source | 2,453Source | 5,039Source | 121,808Source | 1,065,797Source | — | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | 239,935Source | — | 239,935Source | — | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | 13,099Source | 13,099Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,191,455Source | -1,757,038Source | -3,007,809Source | -2,175,493Source | -1,613,888Source | -2,311,037Source | -10,473,672Source | -8,399,166Source | -10,955,295Source | -8,717,608Source |
| Nonoperating Income (Expense)USD | — | — | — | 1,367Source | -942,442Source | -2,453Source | -5,039Source | -466,720Source | -1,410,710Source | -343,446Source | -333,955Source | 15,844Source |
| Operating ExpensesUSD | — | — | 2,336,167Source | 2,280,221Source | 2,285,425Source | 2,352,598Source | 1,832,166Source | 2,031,043Source | 9,817,713Source | 9,050,575Source | 11,360,866Source | 9,123,797Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 147,802Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 150,000Source | — | 675,000Source | 2,050,100Source | — | 137,500Source |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | — | — | — | — | -320,404Source | -320,404Source | -106,513Source | — | — |
| Amortization of Debt Issuance Costs and Discounts | — | — | —Source | — | —Source | — | — | — | — | — | — | — |
| Gain (Loss) on Termination of Lease | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Operating Lease, Impairment Loss | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Other Nonoperating Income (Expense) | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 286,108Source | 583,313Source | 303,284Source | 200,720Source | 337,572Source | 297,500Source | 1,141,607Source | 1,132,533Source | 968,706Source | 917,162Source |
| Cost of RevenueUSD | — | — | 141,396Source | 61,497Source | 83,226Source | 21,162Source | 114,255Source | 110,774Source | 386,856Source | 137,677Source | 229,180Source | 526,817Source |
| Operating Income (Loss)USD | — | — | -2,191,455Source | -1,758,405Source | -2,065,367Source | -2,173,040Source | -1,608,849Source | -1,844,317Source | -9,062,962Source | -8,055,720Source | -10,621,340Source | -8,733,452Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -2,191,455Source | -1,757,038Source | -3,007,809Source | -2,175,493Source | -1,613,888Source | -2,311,037Source | -10,473,672Source | -8,399,166Source | -10,955,295Source | -8,717,608Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,191,455Source | -1,757,038Source | -3,007,809Source | -2,175,493Source | -1,613,888Source | -2,311,037Source | -10,473,672Source | -8,399,166Source | -10,955,295Source | -8,717,608Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.07Source | -0.09Source | -0.11Source | -0.11Source | -0.05Source | -0.1Source | -0.38Source | -0.41Source | -0.78Source | -0.85Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.07Source | -0.09Source | -0.11Source | -0.11Source | -0.05Source | -0.1Source | -0.38Source | -0.41Source | -0.78Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 33,674,322Source | 20,632,921Source | 27,579,136Source | 20,099,095Source | 37,055,261Source | 24,302,790Source | 30,154,631Source | 20,491,422Source | 13,969,754Source | 10,222,994Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 33,674,322Source | 20,632,921Source | 27,579,136Source | 20,099,095Source | 37,055,261Source | 24,302,790Source | 30,154,631Source | 20,491,422Source | 13,969,754Source | — |
| Interest Expense (non-operating)USD | — | — | — | 24,378Source | 942,442Source | 2,453Source | 5,039Source | 121,808Source | 1,065,797Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 658Source | 1,379Source | 870Source | 1,382Source | 509Source | 1,230Source | 3,216Source | 6,374Source | 8,550Source | 9,803Source |
| General and Administrative ExpenseUSD | — | — | 1,252,406Source | 1,184,807Source | 1,236,730Source | 1,267,117Source | 967,442Source | 1,068,818Source | 4,333,577Source | 4,823,230Source | 6,693,186Source | 5,022,943Source |
| Gross ProfitUSD | — | — | 144,712Source | 521,816Source | 220,058Source | 179,558Source | 223,317Source | 186,726Source | 754,751Source | 994,856Source | 739,526Source | 390,345Source |
| Interest ExpenseUSD | — | — | 0Source | 461Source | — | — | 5,039Source | 121,808Source | 12,667Source | — | — | — |
| Interest Income (Expense), NetUSD | — | — | — | -24,378Source | — | -2,453Source | — | — | — | -359,408Source | -6,463Source | 15,844Source |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | 13,099Source | 13,099Source | — | — | — |
| Nonoperating Income (Expense)USD | — | — | — | 1,367Source | -942,442Source | -2,453Source | -5,039Source | -466,720Source | -1,410,710Source | -343,446Source | -333,955Source | 15,844Source |
| Operating ExpensesUSD | — | — | 2,336,167Source | 2,280,221Source | 2,285,425Source | 2,352,598Source | 1,832,166Source | 2,031,043Source | 9,817,713Source | 9,050,575Source | 11,360,866Source | 9,123,797Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 147,802Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | 125,000Source | — | 125,000Source | — | 125,000Source | 28,603Source | 403,603Source | — | — | — |
| Research and Development ExpenseUSD | — | — | 322,991Source | 371,953Source | 261,433Source | 465,174Source | 233,419Source | 340,513Source | 1,415,032Source | 1,583,250Source | 1,268,014Source | 690,577Source |
| Selling and Marketing ExpenseUSD | — | — | 760,770Source | 723,461Source | 787,262Source | 620,307Source | 631,305Source | 621,712Source | 3,069,104Source | 2,644,095Source | 3,399,666Source | 3,410,277Source |
| Other Nonoperating Income (Expense) | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Depreciation, Depletion and Amortization, Nonproduction | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
Filing attachments
ex99-1.htm · 8-K · 2026-09-22
Exhibit 99.1 5151 Edina Industrial Blvd., Suite 575, Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com PRESS RELEASE: Michael Handley Joins PetVivo Holdings, Inc. Board of Directors MINNEAPOLIS, MN, US, September 22, 2026 - PetVivo Holdings, Inc. (OTCQX: PETV) (the “Company”), together with its subsidiaries PetVivo Animal Health, Inc., Somatrix Technologies, Inc. and PetVivo AI, Inc., an emerging biomedical device company focused on the commercialization of innovative medical devices…
Read attachment ↗ex99-1.htm · 8-K · 2026-09-22
Exhibit 99.1 5151 Edina Industrial Blvd., Suite 575, Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com PRESS RELEASE: Jaime Pickett Joins PetVivo Holdings, Inc. Board of Directors MINNEAPOLIS, MN, US, September 22, 2026 - PetVivo Holdings, Inc. (OTCQX: PETV) (the “Company”), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, today announced the appointment of Jaime K. Pickett, DVM, MBA, to its B…
Read attachment ↗ex99-2.htm · SCHEDULE 13D/A · 2026-09-15
Exhibit 99.2 Transactions - Past 60 days Date Reporting Number Transaction Price Person ──────────────────────────────────────────────────────────────────────── 08/27/26 Mrs. 580 Open $0.687 Sarroff Market Purchase 09/09/26 Mrs. 22,160 Open $0.679 Sarroff Market Purchase 09/10/26 Mr. …
Read attachment ↗ex99-1.htm · 8-K · 2026-07-29
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 5151 Edina Industrial Blvd., Suite 575, Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com PRESS RELEASE: PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM Agreement Resolves All Outstanding Matters and Completes Transition of PrecisePRP® Product Line MINNEAPOLIS, July 28, 2026 - PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) working in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc…
Read attachment ↗ex99-1.htm · 8-K · 2026-06-25
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 5151 Edina Industrial Blvd., Suite 575, Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com PRESS RELEASE: FOR IMMEDIATE RELEASE PetVivo Holdings Annouces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform Acquisition Strengthens Company’s Intellectual Property Portfolio and Creates New Opportunities for Medical Device and Therapeutic Product Development Across Animal and Human Health Markets …
Read attachment ↗